| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.05 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.06 |